Punekar, YS; Hawkins, N; (2010) Cost-effectiveness of infliximab for the treatment of acute exacerbations of ulcerative colitis. The European journal of health economics : HEPAC : health economics in prevention and care, 11. pp. 67-76. DOI: https://doi.org/10.1007/s10198-009-0199-5; 10.1007/s10198-009-0199-5 Full text not available from this repository.